2008Journal of clinical and experimental medicineRequires access

The effects of mifepristone with methytestosterone in the treatment of uterine myoma in primenopausal women

MA Na-xi

Open publisher page 0 citations

Abstract

Objective To determine the clinical effects to mifepristone With methytestosterone administration in perimenopausal women with uterine myome.Methods 57 cases of perimenopausal patients with uterine myoma and abnormal bleeding .The patients were divided into two groups. Group Ⅰ 31 cases was given mifepristone 12.5mg/d with methytestosterone 5mg/d for 3 months. Group Ⅱ 26 cases with methytestosterone only ,dosage was 7.5mg/d,for 3 month.Results In the Group Ⅰ amenorrlea occurred in all cases during the period of treatment,100%,15 cases of them into menopause direct. After treatment the volume of myoma dereased significantly 48.2%(P0.01). In Group Ⅱ amenorrhea occurredin 6 cases,5 patients of them into menopause, and the other 16 cases the abnormal bleeding was cased, and the volumce of myomas in group Ⅱ dereased also, 12.5%(P0.05).Conclusion Mifepristone with methytestosterone administration is effective and safe in treating perimenopausal women with uterine myomas.

About this research paper

What this paper is about

Objective To determine the clinical effects to mifepristone With methytestosterone administration in perimenopausal women with uterine myome.Methods 57 cases of perimenopausal patients with uterine myoma and abnormal bleeding .The patients were divided into two groups. Group Ⅰ 31 cases was given mifepristone 12.5mg/d with methytestosterone 5mg/d for 3 months. Group Ⅱ 26 cases with methytestosterone only ,dosage was 7.5mg/d,for 3 month.Results In the Group Ⅰ amenorrlea occurred in all cases during the period of treatment,100%,15 cases of them into menopause direct. After treatment the volume of myoma dereased significantly 48.2%(P0.01). In Group Ⅱ amenorrhea occurredin 6 cases,5 patients of them into menopause, and the other 16 cases the abnormal bleeding was cased, and the volumce of myomas in group Ⅱ dereased also, 12.5%(P0.05).Conclusion Mifepristone with methytestosterone administration is effective and safe in treating perimenopausal women with uterine myomas.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To determine the clinical effects to mifepristone With methytestosterone administration in perimenopausal women with uterine myome.Methods 57 cases of perimenopausal patients with uterine myoma and abnormal bleeding .The patients were divided into two groups. Group Ⅰ 31 cases was given mifepristone 12.5mg/d with methytestosterone 5mg/d for 3 months. Group Ⅱ 26 cases with methytestosterone only ,dosage was 7.5mg/d,for 3 month.Results In the Group Ⅰ amenorrlea occurred in all cases during the period of treatment,100%,15 cases of them into menopause direct. After treatment the volume of myoma dereased significantly 48.2%(P0.01). In Group Ⅱ amenorrhea occurredin 6 cases,5 patients of them into menopause, and the other 16 cases the abnormal bleeding was cased, and the volumce of myomas in group Ⅱ dereased also, 12.5%(P0.05).Conclusion Mifepristone with methytestosterone administration is effective and safe in treating perimenopausal women with uterine myomas.

Key concepts: Mifepristone, Medicine, Amenorrhea, Myoma, Menopause, Uterine myoma, Gynecology, Obstetrics

Related papers

Back to paper searchBrowse research topicsOriginal source
The effects of mifepristone with methytestosterone in the treatment of uterine myoma in primenopausal women — Research Paper | ScholarLens